Molina Healthcare’s Downgrade Tied To Potential Trump Presidency, Margin Challenges
5
0
Shares of Molina Healthcare Inc (NYSE: MOH) added over 5% last month and showed signs of being overbought.
The company is poised to witness rate pressure in 2025, following a period of elevated margins, according to BofA Securities.
The Molina Healthcare Analyst: Kevin Fischbeck downgraded the rating for Molina Healthcare from Neutral to Underperform, while keeping the price target unchanged at $439.
The Molina Healthcare Thesis: Medicaid-related insurers are likely to witness margin pressure on “large portions of their membership,” Fischbeck said in the downgrade note.
Check out …
Full story available on Benzinga.com
Visited 5 times, 1 visit(s) today